CIC 2014: Award Winners

cic14-logo_b_350x200 - CopyThe Canadian Immunization Conference (CIC) Organizing Committee has announced award winners for the 2014 Distinguished Lecture in Canadian Immunization Award and 2014 John Waters Memorial Award. The award recipients will deliver a plenary lecture at the 2014 CIC taking place in Ottawa, Ontario from December 2-4.

2014 Distinguished Lecture in Canadian Immunization Award
Established in 2008, the Distinguished Lecture in Canadian Immunization Award is granted by the Awards Committee of the CIC every two years. This tribute recognizes outstanding career achievement in the field of Canadian immunization. 

2014 John Waters Memorial Award
The John Waters Memorial Award was initiated in 2002 in recognition of his outstanding leadership in support of immunization programs and policy. The purpose of the Dr. John Waters Memorial Award is to recognize other outstanding contributors to public health and immunization programs.

2014 Distinguished Lecture in Canadian Immunization Award
Presented by: Shalini Desai, Medical Epidemiologist, Public Health OntarioDr S HalperinAward Winner:

Dr.Scott Halperin

Dr. Halperin has been a leader in the field of immunizations over his career.  As an infectious diseases consultant he has cared for patients with vaccine preventable diseases.  He has done pivotal research work that goes from bench to bedside.  He continues to lead national networks such as the Immunization Monitoring Program Active (IMPACT), the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Canadian Immunization Research Network (CIRN) to generate knowledge around vaccine preventable disease surveillance, immunization program practices and knowledge translation.  He has taught and supervised students at a variety of different levels of training, and by doing so has contributed to the future of vaccine research in Canada.

Plenary I: Pregnancy – A time to vaccinateVaccination during pregnancy has the potential to provide benefit to the woman, the fetus, and the newborn infant. While tetanus vaccination during pregnancy has been instrumental during the last 30 years in eliminating neonatal tetanus throughout the developing world, routine tetanus vaccination during pregnancy has lagged behind in more developed countries. Pregnant women are now one of the highest priorities for influenza vaccination globally, and pertussis vaccination during pregnancy has been recommended as a response to high rates of neonatal pertussis deaths. As new vaccines for use in pregnancy are in development for group B streptococcus and for respiratory syncytial virus and with increasing evidence of the safety and effectiveness of maternal immunization, a pregnancy vaccine platform should become as accepted and routine as infant immunization. However, the path to achieve this goal needs to be carefully planned and implemented.

2014 John Waters Memorial Award
Presented by:  Bryce Larke, Dr. John Waters Memorial Committee

EPSON MFP imageAward Winner: Dr. Barbara Law

Over a career spanning 35 years, Dr. Law has made numerous contributions through her clinical and academic work – from the benefits of breastfeeding to appropriate antibiotic therapy for a range of infectious diseases. She participated in numerous vaccine development trials and was a founding member of IMPACT, which up to today forms the backbone of vaccine safety monitoring and surveillance for paediatric infectious diseases in Canada. Through policy committees and working groups, Dr Law has helped drive forward the public health agenda in communicable disease control, immunization and vaccine safety. Dr Law has committed her life and career to the science and promotion of child health and public health programmes across Canada, for the benefit of children everywhere.

Plenary III: Vaccine safety: Through the looking glasses Vaccine safety, perceived as well as real, is critically important to public confidence in vaccines and immunization. This is a global concern and one that involves a very broad range of stakeholders, each with roles and responsibilities. The evidence that informs vaccine safety has lagged behind that for vaccine immunogenicity, efficacy and effectiveness. However, the pace of knowledge generation has accelerated in recent decades thanks to new methodologies and resources.  Many challenges remain. This plenary will look at vaccine safety from a variety of viewpoints in time, space and personal perspective in order to paint a picture of what has gone before, where we stand now and what the future can and should hold.

The CIC is organized by the Canadian Public Health Association (CPHA) in collaboration with the CAIRE, the Canadian Paediatric Society (CPS), and the Centre for Immunization and Respiratory Infectious Diseases at the Public Health Agency of Canada (PHAC)